This growth comes as pharmaceutical companies increasingly rely on CDMOs and CMOs to navigate complex development and manufacturing requirements while maintaining agility and cost-effectiveness.
However, this expansion brings fresh challenges and today's CDMOs face mounting pressure from multiple directions.
Supply chain resilience, sustainability demands and increasing regulatory oversight are reshaping operational priorities. At the same time, the drive towards collaborative partnership models and rising demand for holistic services requires CDMOs to constantly expand their capabilities.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.